Introduction: Patients with hepatocellular carcinoma (HCC) receive Model for End-Stage Liver Disease (MELD) prioritization points. These aim to prevent waiting list drop-out due to tumor progression. This practice has resulted in an imbalance in the access of HCC vs.
View Article and Find Full Text PDF